Program

November 4-8, 2019
Lima, Peru



Confirmed speakers


Bo Lönnerdal, PhD
University of California, Davis, USA
“Biological activities of the human milk lactoferrin-osteopontin complex”

Hans Vogel, PhD
University of Calgary, Canada
“Antibiofilm and anticancer activities of lactoferrin-derived antimicrobial peptides”

Nidia Leon-Sicarios, PhD
Universidad Autónoma de Sinaloa, México
“Lactoferrin and lactoferrin peptides against multi-drug resistant bacteria”

Jianhua Wang, PhD
Chinese Academy of Agricultural Sciences, P.R. China
“Molecular modification and characteristics of lactericcin deriavates of anti-trypsin proteolysis”

Anthony B. Schryvers, MD, PhD
University of Calgary, Canada
“Bacterial lactoferrin receptors – An Evolutionary Perspective”

Piera Valenti, PhD
Sapienza University of Rome, Italy
“Antimicrobial and anti-inflammatory activity of lactoferrin in in vitro and in vivo models”

Vadim Vasilyev, PhD
Institute of Experimental Medicine, Saint-Petersburg, Russia
“Lactoferrin rescues cognitive functions in the offspring of rats subjected to hypoxia in pregnancy”

Jeffrey K. Actor, PhD
University of Texas Health Science Center at Houston, USA
“Lactoferrin Treatment Alters Macrophage Phenotypes to Permit Drug Penetration to Mycobacterial Granulomas”

Marian Kruzel, PhD
University of Texas Health Science Center at Houston, USA
“Systemic effects of dietary lactoferrin: bioequivalence of human versus bovine lactoferrin”


Special Symposium on Neonatal Sepsis and Lactoferrin

  • Janet Berrington MD, Newcastle University, UK
  • David Kaufman MD, University of Virginia School of Medicine, USA
  • Petra S. Huppi, MD, Hôpitaux Universitaires de Genève, Switzerland
  • Theresa J. Ochoa MD, Universidad Peruana Cayetano Heredia, Peru
  • Paolo Manzoni MD, Ospedale degli Infermi, Italy (to be confirmed)
  • William Tarnow-Mordi MD, University of Sydney, Australia (to be confirmed)